Photoaffinity labeling of benzophenone-containing salicylanilide compounds to give an insight into the mechanism in disrupting peptidoglycan formation

Bioorg Med Chem. 2022 Aug 1:67:116819. doi: 10.1016/j.bmc.2022.116819. Epub 2022 May 13.

Abstract

A series of salicylanilide compounds was previously identified as antibacterial agents that inhibit the peptidoglycan formation. To find the exact binding mode, we synthesized a benzophenone-containing salicylanilide compound (1) and used it as a photoaffinity probe to label Acinetobacter baumannii penicillin-binding protein (PBP1b). After incubation and photo-irradiation, the labeled protein was subjected to trypsin digestion, dialysis enrichment, LC-ESI-MS/MS analysis, and Mascot search to reveal an octadecapeptide sequence 364RQLRTEYQESDLTNQGLR381 that was labeled at E372. Our molecular docking experiments suggest a hydrophobic pocket surrounded by R367 and E372 is the binding site of salicylanilide 1. The pocket lies in between the transglycosylase and transpeptidase domains, thus binding of salicylanilide 1 can block the propagation pathway to disrupt the growth of peptidoglycan chain.

Keywords: Antibacterial agent; Molecular docking; Peptidoglycan; Photoaffinity labeling; Salicylanilide compound.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Benzophenones / pharmacology
  • Escherichia coli / metabolism
  • Molecular Docking Simulation
  • Peptidoglycan
  • Peptidoglycan Glycosyltransferase* / chemistry
  • Peptidoglycan Glycosyltransferase* / metabolism
  • Photoaffinity Labels
  • Salicylanilides
  • Tandem Mass Spectrometry

Substances

  • Benzophenones
  • Peptidoglycan
  • Photoaffinity Labels
  • Salicylanilides
  • Peptidoglycan Glycosyltransferase